HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Genomic loss and epigenetic silencing of very-low-density lipoprotein receptor involved in gastric carcinogenesis.

Abstract
Homozygous loss in the genomic sequence, a mechanism for inactivating tumor-suppressor genes (TSGs) in cancer, has been used as a tag for the identification of novel TSGs, and array-based comparative genomic hybridization (array-CGH) has a great potential for high-throughput identification of this change. We identified a homozygous loss of the very-low-density lipoprotein receptor (VLDLR) gene (9p24.2) from genome-wide screening for copy-number alterations in 32 gastric cancer (GC) cell lines using array-CGH. Although previous reports demonstrated mRNA or protein expression of VLDLR in various cancers including GC, the association between genomic losses or epigenetic silencing of this gene and carcinogenesis has never been reported before. Homozygous deletion of VLDLR was also seen in primary GCs, albeit infrequently, and about half of GC cell lines showed lost or reduced VLDLR expression. The VLDLR expression was restored in gene-silenced GC cells after treatment with 5-aza 2'-deoxycytidine. According to methylation analyses, hypermethylation of the VLDLR promoter region, which all of GC lines without its expression showed, occurred in some primary GCs. Restoration of VLDLR type I expression in GC cells reduced colony formation. These results suggest that not only the expression of VLDLR but also genetic or epigenetic silencing of this gene may contribute to tumor formation and be involved in gastric carcinogenesis.
AuthorsH Takada, I Imoto, H Tsuda, Y Nakanishi, C Sakakura, S Mitsufuji, S Hirohashi, J Inazawa
JournalOncogene (Oncogene) Vol. 25 Issue 49 Pg. 6554-62 (Oct 19 2006) ISSN: 0950-9232 [Print] England
PMID16715143 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Receptors, LDL
  • VLDL receptor
Topics
  • Biopsy
  • Carcinoma (genetics, metabolism, surgery)
  • Cell Proliferation
  • Cell Transformation, Neoplastic
  • Chromosomes, Human, Pair 9
  • CpG Islands
  • DNA Methylation
  • Epigenesis, Genetic
  • Gene Deletion
  • Gene Silencing
  • Homozygote
  • Humans
  • Nucleic Acid Hybridization (methods)
  • Oligonucleotide Array Sequence Analysis (methods)
  • Promoter Regions, Genetic
  • Receptors, LDL (genetics, metabolism)
  • Stomach Neoplasms (genetics, surgery)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: